Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results
|
Syndax Pharmaceuticals Inc (SNDX)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
10/05/2023 |
SC 13G/A
| Frazier Life Sciences Public Fund, L.P. reports a 0% stake in Syndax Pharmaceuticals, Inc. |
02/14/2023 |
SC 13G/A
| Nantahala Capital Management, LLC reports a 1.4% stake in Syndax Pharmaceuticals, Inc. |
02/14/2023 |
SC 13G/A
| Avidity Partners Management LP reports a 9.7% stake in Syndax Pharmaceuticals, Inc. |
02/14/2023 |
SC 13G/A
| Frazier Life Sciences Public Fund, L.P. reports a 5.4% stake in Syndax Pharmaceuticals, Inc. |
02/14/2023 |
SC 13G/A
| BIOTECHNOLOGY VALUE FUND L P reports a 2.1% stake in Syndax Pharmaceuticals, Inc. |
02/06/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/14/2022 |
SC 13G/A
| BIOTECHNOLOGY VALUE FUND L P reports a 8.9% stake in Syndax Pharmaceuticals, Inc. |
02/11/2022 |
SC 13G/A
| Avidity Partners Management LP reports a 9.9% stake in Syndax Pharmaceuticals, Inc. |
02/10/2022 |
SC 13G/A
| ADAGE CAPITAL PARTNERS GP, L.L.C. reports a 2.3% stake in Syndax Pharmaceuticals, Inc. |
02/07/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/04/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
04/20/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/16/2021 |
SC 13G/A
| Avidity Partners Management LP reports a 7.1% stake in Syndax Pharmaceuticals, Inc. |
02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/04/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/03/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
12/10/2020 |
SC 13G/A
| WELLINGTON MANAGEMENT GROUP LLP reports a 5.3% stake in Syndax Pharmaceuticals Inc |
02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/12/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/06/2020 |
SC 13G/A
| BlackRock Inc. reports a 6.3% stake in SYNDAX PHARMACEUTICALS INC |
01/28/2020 |
SC 13G/A
| WELLINGTON MANAGEMENT GROUP LLP reports a 11.2% stake in Syndax Pharmaceuticals Inc |
02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/12/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/11/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/14/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/08/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/02/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
12/11/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
12/07/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
|
|
|